Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
AXGN
AXGN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
AXGN News
Conexeu Sciences Inc. Goes Public, Pioneering a New Era in Regenerative Medicine
May 22 2026
Globenewswire
Conexeu Sciences Inc. Goes Public, Pioneering a New Era in Regenerative Medicine
May 22 2026
Newsfilter
TELA Bio Announces Board Refreshment Plan for Growth
Apr 30 2026
Globenewswire
Axogen Q1 2026 Earnings: Revenue Growth and Upgraded Outlook
Apr 28 2026
seekingalpha
Axogen Reports 26.6% Revenue Growth in Q1 2026
Apr 28 2026
NASDAQ.COM
AxoGen Reports Q1 Revenue Growth of 26.6% with Positive Outlook
Apr 28 2026
seekingalpha
Capricorn Fund Managers Acquires Stake in Axogen
Apr 26 2026
Fool
Capricorn Fund Increases Stake in Axogen
Apr 26 2026
NASDAQ.COM
CVRx Nominates Michael Dale to Board of Directors
Apr 20 2026
Globenewswire
CVRx Nominates Michael Dale to Board of Directors
Apr 20 2026
Newsfilter
Axogen Executive Exercises Stock Options, Sells Shares
Mar 24 2026
Fool
DAFNA Capital Management Reduces AXGN Holdings
Mar 22 2026
NASDAQ.COM
DAFNA Capital Management Reduces Axogen Holdings
Mar 22 2026
Fool
Axogen Reports Q4 2025 Earnings with Strong Growth and FDA Milestone
Feb 24 2026
seekingalpha
HighMark Wealth Management Increases Axogen Stake to 4.6%
Feb 24 2026
Fool
HighMark Wealth Management Increases Axogen Stake to 4.6% of AUM
Feb 24 2026
NASDAQ.COM
Show More News
